T
TRiCares
Biotech & Life Sciences · Aschheim, Germany · Founded 2013
Device designed for minimally invasive treatment of tricuspid regurgitation MoreLess
TRiCares is a medical device startup, founded in 2013, that operates in the rapidly growing transcatheter heart valve replacement market. The company's primary focus is on the development of a catheter-based tricuspid valve replacement system. This system is designed to help patients suffering from Tricuspid Regurgitation (TR), a serious heart complication where the tricuspid valve does not close properly, causing blood to flow back into the right atrium. This condition affects over 12.7 million patients in Europe alone.
TRiCares' innovative solution aims to treat TR without the need for open-heart surgery, offering a less invasive alternative to traditional surgical methods. This is particularly significant given the high-risk nature of open-heart surgeries and the potential for a faster recovery time with minimally invasive procedures.
The company's business model revolves around the development, production, and sale of these catheter-based systems to healthcare providers. By offering a unique and effective solution to a widespread health issue, TRiCares is well-positioned to capture a significant share of the heart valve replacement market.
The company is headquartered in Paris, France, with an additional office in Munich, Germany, serving a broad European market. TRiCares' potential for growth is substantial, given the high prevalence of heart valve disease and the increasing demand for minimally invasive treatment options.
Keywords: Medical Device Startup, Tricuspid Regurgitation, Catheter-Based System, Heart Valve Replacement, Minimally Invasive, Healthcare Providers, European Market, Heart Valve Disease, Innovative Solution, Market Growth.
Company overview
TRiCares company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2013
- Headquarters
- Aschheim, Germany
- Employees
- 40
- Open positions
- None listed
- Dealroom signal
- 96.0
Valuation & funding
TRiCares funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Jan 2026 | $0 | — | European Investment Bank | ↗ |
| SERIES DOther financing | Jul 2024 | $50M | $200M | Undisclosed | ↗ |
| SERIES COther financing | Sep 2022 | $56M | $224M | BioMedVC · GO Capital · Crédit Mutuel Equity · Karista | ↗ |
| GRANTOther financing | Dec 2018 | $4.8M | — | Undisclosed | — |
| GRANTOther financing | Jul 2018 | $2.8M | — | European Innovation Council | — |
| SERIES BOther financing | Jun 2018 | Wellington Partners · BioMedVC · GO Capital · Andera Partners | ↗ | ||
| EARLY VCOther financing | Oct 2016 | Karista | — | ||
| SEEDOther financing | Sep 2015 | Karista | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $0 | — | −$9M | — |
| 2025 | $0 | — | −$9M | — |
| 2024 | $0 | — | −$9M | — |
| 2023 | $0 | — | −$9M | — |
| 2022 | $0 | — | −$9M | — |
| 2021 | $0 | — | −$9M | — |
| 2020 | $0 | — | −$7.4M | — |
Growth signals
TRiCares website traffic
Latest recorded traffic for TRiCares is 400 monthly website visits, down 87.1% over the last three months. TRiCares's team grew 0% over the past year.
Comparisons
TRiCares compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
TRiCares's talent
Source: Dealroom Talent Intelligence.
Investors
9 investors on TRiCares's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where TRiCares has talent and traffic
team presence
In the news
Latest news about TRiCares
Recent press, funding announcements, and product moves mentioning TRiCares — open to read from the original sources.
Market sentiment
What the market is saying about TRiCares
An AI-synthesized read of the highest-engagement posts about TRiCares on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TRiCares’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.